A61K 9 - Medicinal preparations characterised by special physical form

Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
11/2004
11/30/2004	CA2134680C Tissue-specific implantable therapeutic agent delivery system
11/27/2004	CA2467410A1 Method for treatment of glaucoma and ocular hypertension with prostaglandin analgoues without melanogenic side-effect
11/25/2004	WO2004101758A2 Composition for maintaining organ and cell viability
11/25/2004	WO2004100994A2 Method for the production of a stable injectable formulation made of difficult to dissolve antineoplastic active substances
11/25/2004	WO2004100993A1 Composition for ophthalmic use
11/25/2004	WO2004100984A1 Endogenous adjuvant molecules and uses thereof
11/25/2004	WO2004100965A1 Immunostimulant
11/25/2004	WO2004100959A1 External patch containing estrogen and/or progestogen
11/25/2004	WO2004100944A1 Bicalutamide forms, compositions, and processes thereof
11/25/2004	WO2004100941A1 Pharmaceutical compositions
11/25/2004	WO2004100935A2 Propofol formulation containing reduced oil and surfactants
11/25/2004	WO2004100933A1 Hard gelatin capsule containing titanium oxide with a controlled particle size and process for producing the same
11/25/2004	WO2004100932A1 Controlled drug release composition resistant to in vivo mechanic stress
11/25/2004	WO2004100931A2 Use of soaps such as magnesium stearate for increasing the release of drugs
11/25/2004	WO2004100930A1 Pharmaceutical dosage form comprising a solid solution
11/25/2004	WO2004100929A1 Threo-dops controlled release formulation
11/25/2004	WO2004100928A1 Injectable liposomal depots for delivering active ingredients
11/25/2004	WO2004100927A2 Injectable depots consisting of liposomal aggregates for the delivery of active substances
11/25/2004	WO2004100925A2 Dissolvable backing layer for use with a transmucosal delivery device
11/25/2004	WO2004100924A2 Method of preparing a formulation containing a microdosed active principle
11/25/2004	WO2004100894A2 Drug formulations having reduced abuse potential
11/25/2004	WO2004100883A2 Method for preparing thermoformed compositions containing acrylic polymer binders, pharmaceutual dosage forms and methods of preparing the same
11/25/2004	WO2004100876A2 The aerosolization of cromolyn sodium using a capillary aerosol generator
11/25/2004	WO2004100872A2 Liquid aerosol formulations containing insulin and aerosol generating devices and methods for generating aerosolized insulin
11/25/2004	WO2004100866A2 Alcohol-free transdermal analgesic composition
11/25/2004	WO2004100860A2 Stable liposomes for microencapsulation of animal venoms
11/25/2004	WO2004100857A2 Highly plastic granules for making fast melting tablets
11/25/2004	WO2004100685A1 Mold inhibitor integrated within a matrix and method of making same
11/25/2004	WO2004100681A1 Method for producing a chitosan containing salt having a function of lowering blood pressure
11/25/2004	WO2004091639A3 Lipid extract from fruit of low lipid content
11/25/2004	WO2004089239A3 Topical anthelmintic veterinary formulations
11/25/2004	WO2004087115A3 Combination compositions of camptothecins and fluoropyrimidines
11/25/2004	WO2004087094A3 Nano-sized vehicles transporting a therapeutic agent and at least one drug resistance modulator for the treatment of multi drug resistance
11/25/2004	WO2004084856A3 Novel galenical system for active transport, method for preparation and use
11/25/2004	WO2004082615A3 A process for preparing sustained release tablets
11/25/2004	WO2004082607A3 A method of preparing gas-filled polymer matrix microparticles useful for delivering drug
11/25/2004	WO2004080399A3 Rapidly absorbing lipophilic skin compositions and uses therefor
11/25/2004	WO2004073637A3 Compositions comprising a defined polysaccharide component
11/25/2004	WO2004073607A3 Use of steroids to treat ocular disorders
11/25/2004	WO2004069286A3 Transdermal therapeutic system suitable for heat application for promoting the permeation of active substances, and the use thereof
11/25/2004	WO2004069284A3 Ultrasound contrast agents and process for the preparation thereof
11/25/2004	WO2004060473A3 Active agent delivery device having composite members
11/25/2004	WO2004060378A3 Compositions comprising particles containing alumina with compounds bound to the alumina surface, delivery systems and methods of preparation thereof
11/25/2004	WO2004060298A3 Fast dissolving films for oral administration of drugs
11/25/2004	WO2004056335A3 Delivery device containing venlafaxine and memantine and use method thereof
11/25/2004	WO2004004683A8 Solid dispersions comprising two different polymer matrixes
11/25/2004	WO2003090599A3 Methods and apparatus for modifying properties of the bbb and cerebral circulation by using the neuroexcitatory and/or neuroinhibitory effects of odorants on nerves in the head
11/25/2004	WO2003000006A3 Stackable low depth tray
11/25/2004	US20040236416 Increased biocompatibility of implantable medical devices
11/25/2004	US20040236098 Tocopheryl retinyl succinate, tocopheryl cholecalciferyl succinate or tocopheryl ascorbyl succinate; sustained releasing active agents or vitamin by hydrolyzing with esterase contained in the skin; dermatology, cosmetics
11/25/2004	US20040236097 Branched cyclic tetrasaccharide, process for producing the same, and use
11/25/2004	US20040236095 formed by readcting chitosan with iminothiolane; improved viscoelasticity and gelation; for use in hair gels, eye drops, stents, and tissue engineering
11/25/2004	US20040235964 Stable clear solution of sterile propofol solution in water
11/25/2004	US20040235935 A statin derivative suspended in at least an oily excipient: for releasing water free suspension in gastrointestinal system
11/25/2004	US20040235917 Suspension, ointment, solution, spray, lotion, gel, cream, powder, powder spray, paste, emulsion, foam or stick; for treatment of herpes infections in humans
11/25/2004	US20040235885 Novel composition and method for stabilizing the same
11/25/2004	US20040235881 Immune response modifiers for the treatment of periodontal disease
11/25/2004	US20040235818 Aromatic sulfone hydroxamic acid metalloprotease inhibitor
11/25/2004	US20040235807 Administering formulation for intranasal drug administration, wherein the formulation comprises: a topically administrable decongestant;a topically administrable corticosteroid: and carrier that is suitable for nasal drug administration
11/25/2004	US20040235795 Administration of an agent produced from phosphatidylserine (PS), lyso-phosphatidylserine or/and a physiologically acceptable salt thereof in combination with additive selected from a group comprising antioxidants, essential fatty acids, mineral substances, amino acids, mood-lifters, phospholipids
11/25/2004	US20040235770 Topically administered to treat cancer and infections
11/25/2004	US20040235753 Oxytocin agonists
11/25/2004	US20040235748 Agents for preventing postoperative recurrence of premenopausal breast cancer
11/25/2004	US20040235742 Water channel opener compositions and medicinal compositions for ophthalmic use
11/25/2004	US20040235731 package contains low molecular weight peptide-based thrombin inhibitors (melagatran), sealed with rubber stopper/plunger
11/25/2004	US20040235730 Non-naturally occurring lipoprotein particle
11/25/2004	US20040235727 Comprising H 376/95, sodium dodecyl sulphate, and a polymer selected from hydroxypropyl methylcellulose, hydroxyethyl cellulose, and polyoxyethylene oxide; use in treatment of thromboembolism
11/25/2004	US20040235114 Immunogenic compounds
11/25/2004	US20040235044 Chain-shortened polynucleotide and method for preparation thereof
11/25/2004	US20040234761 Two part hard shell capsule made of poly(1,4-alpha-d-glucan) and starch
11/25/2004	US20040234676 contacting a gas with a fluid comprising cellulose ether, cellulose ester, polyalkylene oxide, or homo- or copolymer of vinyl alcohol or vinylpyrrolidone, and a liquid diluent, preferably water, to produce a foam, and contacting the foam with solid particles and agitating
11/25/2004	US20040234634 Pharmaceutical compositions having appetite suppressant activity
11/25/2004	US20040234633 Composition containing horse chestnut extract
11/25/2004	US20040234628 Topical composition for the treatment of skin disorders and methods of using the same
11/25/2004	US20040234626 Food supplement for increasing lean mass and strength
11/25/2004	US20040234616 Long acting injectable insulin composition and methods of making and using thereof
11/25/2004	US20040234615 Oral insulin composition and methods of making and using thereof
11/25/2004	US20040234614 Chitin microparticles and their medical uses
11/25/2004	US20040234611 Active material embedded into biocompatible polymer or lipid
11/25/2004	US20040234608 Rapidly expanding composition for gastric retention and controlled release of therapeutic agents, and dosage forms including the composition
11/25/2004	US20040234606 Localized vaginal delivery without detrimental blood levels
11/25/2004	US20040234602 Polymer release system
11/25/2004	US20040234601 Absorption in upper part oof digestive system; oral administering
11/25/2004	US20040234600 Sustained release dosage form: layer containing polyethylene glycol, polyvinylpyrrolidone and lubricant
11/25/2004	US20040234599 Composition and method for maintaining healthy mobile joints and cartilage
11/25/2004	US20040234598 Sustained release heterodisperse hydrogel systems for insoluble drugs
11/25/2004	US20040234597 pH triggered site specific targeted controlled drug delivery system for the treatment of cancer
11/25/2004	US20040234596 Fast disintegrating meloxicam tablet
11/25/2004	US20040234594 Inhibiting gastric acid secretory; antiulcer agent; oral dosage form
11/25/2004	US20040234593 Diphenhydramine tannate compositions and methods of use
11/25/2004	US20040234591 Hard gelatin capsule and process for producing the same
11/25/2004	US20040234590 Film forming envelope encloding core; food, drugs, oral hygiene, cosmetics
11/25/2004	US20040234589 Mixture with carrier; storage stability packaging; freeze drying
11/25/2004	US20040234588 Artificial lipoprotein carrier system for bioactive materials
11/25/2004	US20040234585 multilayer lamination; reducing smoking
11/25/2004	US20040234584 Transdermal therapeutic system with fentanyl or related substances
11/25/2004	US20040234583 Transdermal therapeutic system (tts) with fentanyl as a active ingredient
11/25/2004	US20040234582 Mixture of addition copolymer and softener; transdermal
11/25/2004	US20040234581 Disposable facial mask
11/25/2004	US20040234578 Bioadhesive, closed-cell foam film, sustained release, delivery devices and methods of making and using same

1 ... 1905 1906 1907 1908 1909 1910 1911 1912 1913 1914 1915 1916 1917 1918 1919 1920 1921 1922 1923 1924 1925 ... 2991